Cognition Studio, Inc.

Mini-Protein Binder Designs Against the Flu Virus 

Prev Next
Previous

Inari: The Seed Revolution

medical illustration of Researchers at the UW Institute for Protein Design (IPD) are revolutionizing how new de novo protein drugs, or “mini-protein binders,” can be generated. To support their publication and media efforts, Cognition created this editorial visualization to highlight their integration of computational design and laboratory testing, which rapidly generates and evaluates thousands of binders to find the best conformation to neutralize a specific target, such as hemagglutinin on the flu virus.
Next medical illustration of Scientists at the UW Institute for Protein Design (IPD) are pioneering the first synthetic nucleocapsids capable of packaging their genetic material and evolving specific properties. To support their publication and media efforts, Cognition created this editorial science visualization to highlight their elegant synthetic biology system that utilizes computational design and evolves based on exposure to complex environments (such as RNase A, blood, and murine circulation).

Design and Evolution of Synthetic Nucleocapsids

Researchers at the UW Institute for Protein Design (IPD) are revolutionizing how new de novo protein drugs, or “mini-protein binders,” can be generated. To support their publication and media efforts, Cognition created this editorial visualization to highlight their integration of computational design and laboratory testing, which rapidly generates and evaluates thousands of binders to find the best conformation to neutralize a specific target, such as hemagglutinin on the flu virus.

Keywords: Color, 3D, Advertising / Marketing, Editorial, Technology, Biology, Biotechnology, Molecular Biology, Virology, Mechanism of Action (MOA)

Cognition Studio, Inc.